ArticleThe journal of pathology. Clinical research2023

RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test.

Claire Jh Kramer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.